Montefiore Einstein Center for Cancer Care

NCAN’s 13th Annual ‘Celebration of Life’ Gala and the ‘Above and Beyond’ Award Honoree

~ Tricia Wahmann-Knatz ~ Leave a comment

setup3

Saturday, November 12th, 2016 was NCAN’s 13th Annual ‘Celebration of Life’ Gala in Bethpage, NY. Held at The Sterling, it was a beautiful evening of dancing, raffles, laughs, and good food!

The Gala is always one of my favorite fundraisers because it really is a celebration. We take the time to not only focus on the cause of NET Cancer, its awareness and fundraising but taking a moment to really enjoy and celebrate time with family and friends.

Every year at the ‘Celebration of Life’ Gala, NCAN takes the opportunity to honor someone who is invaluable to the NET community by presenting the ‘Above and Beyond’ award. Past recipients include Dr. Hal Gerstein, also honoring Dr. Gene Woltering and Dr. Tom O’Dorisio. This year, NCAN has honored Dr. Edward Wolin who is very well known throughout the community for his commitment to NET Cancer and his patients.

gala_award_poster_2016-r1-page-0

As Director of the Neuroendocrine Tumor Program at Montefiore Einstein Center for Cancer Care, Dr. Wolin brings a robust research program to Montefiore, including multiple clinical trials. His research efforts focus on finding treatments which are more effective and less toxic, including m-TOR inhibitors, targeted radiation including PRRT, anti-angiogenic drugs, novel targeted biologic anti-cancer treatments, and targeted treatment of liver metastases. Dr. Wolin’s research is also directed at development of new imaging and diagnostic procedures for carcinoid/neuroendocrine tumors.

Dr. Wolin is an internationally recognized Neuroendocrine Medical Oncologist. Patients from all over the United States and abroad come to see him for access to personalized care and the latest diagnostic and therapy programs.

Dr. Wolin was previously the Director of Neuroendocrine and GI Oncology Program and the Director of Clinical Research at the University of Kentucky Medical Center.  For the preceding 26 years, he held key positions at Cedars–Sinai Medical Center in Los Angeles, where he founded and directed of one of the largest and most productive Carcinoid and Neuroendocrine Tumor Programs in the country. As you can see, Ed Wolin is one of the foremost experts and best friends that neuroendocrine cancer patients have! For more information on how to reach Dr. Wolin, you can check out a brief profile on him from a previous post here.

wolin&wife.jpg
 

‘Above and Beyond’ Award Honoree – Dr. Ed Wolin and his wife, Susan.

 

Overall, it was a very successful night for NCAN and the NET community. Take a look here at some of NCAN’s wonderful prizes, the big winners of the TV, and one of the delicious cakes!

For more information on how YOU can get involved with NCAN’s 14th Annual ‘Celebration of Life’ Gala on November 11th, 2017, keep your eyes out here and be sure to watch out at NETCANCERAWARENESS.ORG for details! For help in hosting your own fundraising event for NET Cancer near YOU, send me a message here and I’d be happy to assist you.

NCAN would really love to thank all of the volunteers, donors, attendees, and sponsors for all of their time and support! Without you, events like this amazing night would not be possible!

NCAN’s 13th Annual ‘Celebration of Life’ Gala was sponsored by:

The Speaker Spotlight – 2016 National Conference Edition

~ Tricia Wahmann-Knatz ~ 2 Comments

Welcome to the NETCancerAwarenessBlog’s first of the Speaker Spotlight Series-2016 National Conference Edition!!

drwolin

Edward M. Wolin, MD

Director, Neuroendocrine Tumor Program, Montefiore Einstein Center for Cancer Care

Montefiore

Department: Oncology

Bio:

Edward M. Wolin, MD is an internationally recognized Neuroendocrine Medical Oncologist. Patients from all over the United States and abroad come to see him for access to personalized care and the latest diagnostic and therapy programs.   

Dr. Wolin graduated from Reed College in Portland, Oregon, and received his MD degree From Yale School of Medicine at Yale University in New Haven, Connecticut.  After serving as intern and resident in Internal Medicine at Stanford University, he became a clinical fellow at the National Cancer Institute in Bethesda, Maryland.  He returned to Stanford to complete his Fellowship in Medical Oncology before starting his academic career at the faculty of Washington University School of Medicine in St. Louis, Missouri.

Dr. Wolin was previously the Director of Neuroendocrine and GI Oncology Program and the Director of Clinical Research at the University of Kentucky Medical Center.  For the preceding 26 years, he held key positions at Cedars–Sinai Medical Center in Los Angeles, where he founded and directed of one of the largest and most productive Carcinoid and Neuroendocrine Tumor Programs in the country.

Clinical Focus:

Dr. Wolin treats all types of carcinoid and neuroendocrine tumors, ranging from tumors of the small intestine (carcinoid), pancreas, lung and colon to those of the rectum, appendix, stomach and other sites. These include hormone-producing tumors such as carcinoid (serotonin), gastrinoma (gastrin), insulinoma (insulin), glucagonoma (glucagon), VIPoma (VIP); liver metastasis, and carcinoid syndrome. 

Dr. Wolin is a critical member of Montefiore’s outstanding multidisciplinary neuroendocrine team, that includes medical oncologists, surgeons, gastroenterologists, endocrinologists, as well as specialists in nuclear medicine, interventional radiology, diagnostic radiology, and other areas.

Research Focus:

As Director of the Neuroendocrine Tumor Program at Montefiore Einstein Center for Cancer Care, Dr. Wolin brings a robust research program to Montefiore that supports multiple clinical trials. His research efforts focus on finding the most effective and least toxic treatments, such as pasireotide, lanreotide, everolimus, other m-TOR inhibitors, targeted radiation, including peptide receptor radiotherapy with Lu-177.

Dr. Wolin has pioneered the development of neuroendocrine tumor therapy with novel somatostatin analogs, mTOR inhibitors, anti-angiogenic drugs, and peptide receptor radiotherapy (PRRT) using 177Lu-DOTATATE, as well as PET imaging with 67GA-DOTATATE scanning.

His research also pursues new directions in immunotherapy, anti-angiogenic drugs, novel targeted biologic anti-cancer treatments, as well as targeted treatment of liver metastases. In addition, Dr. Wolin directs his research towards the development of new imaging and diagnostic procedures for carcinoid/neuroendocrine tumors.

To make an appointment, please call:

Montefiore M-E Center for Cancer Center                                                                         1521 Jarrett Place                                                                                                                  Bronx, NY 10461-2601                                                                                                            (718) 862-8840

Dr. Wolin at the 2016 National NET Patient Conference:

Topic: The Role of Chemotherapy in Well-Differenciated NETs

When: Friday, September 23, 2016 at 2PM*

Be sure not to miss Dr. Wolin speak! And don’t miss him on our panel answering your questions!!

For additional info on Dr. Ed Wolin, please see his profile here.

If you would like to read some of Dr. Wolin’s pulications on PubMed, you can do so here.

SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. Wolin and 19 other experts speak on Neuroendocrine Cancer! 

Registration is $125 per person including

  • Thursday’s Welcome Reception 
  • Breakfast, Lunch, and snacks for both Friday and Saturday
  • And keep your eyes out for some special prizes!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket, click here!!

*Time and Date are subject to change.